In part three of our dedifferentiated liposarcoma expert commentary, Dr. Edwin Choy discusses clinical trials and the molecular biology of dedifferentiated liposarcoma.
KOL Commentary
KOL Commentary
In part three of our dedifferentiated liposarcoma expert commentary, Dr. Edwin Choy discusses clinical trials and the molecular biology of dedifferentiated liposarcoma.